ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2020

Clinical Characteristics In Japanese Patients With IgG4-Related Disease

Kazu Hamada, Yoshinori Taniguchi, Yoshiko Shimamura, Koji Ogata, Kosuke Inoue, Taro Horino, Yoshitaka Kumon, Kahori Hirose, Masamitsu Hyodo and Yoshio Terada, MD, Nankoku, Japan

Meeting: 2013 ACR/ARHP Annual Meeting

Keywords: IgG4 Related Disease

  • Tweet
  • Email
  • Print
Session Information

Title: Miscellaneous Rheumatic and Inflammatory Diseases II: Miscellaneous Rheumatic Diseases

Session Type: Abstract Submissions (ACR)

Background/Purpose: IgG4-related disease (IgG4-RD) is the new entity, which is a multisystem and fibroinflammatory condition. It is characterized by progressive scarring and dysfunction of affected organs and tissues including the pancreas, hepatobiliary tree, kidneys, salivary glands, retroperitoneum and lungs, etc. New diagnostic imaging methods for IgG4-RD have been sought. Recent several reports showed that FDG-PET/CT scans accurately, and safely identifies the multiple organs’ involvements in IgG4-RD patients. To evaluate clinical characteristics, including laboratory and FDG-PET/CT findings, of Japanese patients with IgG4-RD.

Methods: The clinical symptoms, laboratory, pathological and FDG-PET/CT findings of Japanese patients with IgG4-RD (n=13) were assessed. Several laboratory data of IgG4-RD with multiple organs’ involvements (n=6), IgG4-RD with limited organ’s involvement (n=7) and ANCA-associated vasculitis, one of hyper-IL-6 syndromes, (n=10) were comparatively examined. All data are presented as mean ± SD.

Results: IgG4-RD patients (mean age 68±11; male/female 10/3) had xerostomia and bilateral submandibular glands enlargement. As complication, 3 had bronchial asthma, 2 had chronic thyroiditis and 1 had ulcerative colitis. FDG-PET/CT imaging revealed enlargement and increase of FDG accumulation of the bilateral submandibular glands, mediastinal lymph node, lung, spleen, kidney, periaorta and prostate. Interestingly, a part of these organs was asymptomatic. Follow-up FDG-PET/CT after steroid treatment, with no symptoms, showed a significant decrease in FDG accumulation in IgG4-RD lesions. The serum IgG4 level was 847±711 mg/dl (normal 8-135 mg/dl). Four cases with hypocomplementemia and elevated immunocomplex of 13 IgG4-RD cases revealed renal involvements (tubulointerstitial nephritis), and moreover, these 4 cases also had interstitial lung involvements. Notably, cholinesterase (ChE) and total cholesterol (T-cho) levels in IgG4-RD cases with multiple organs’ involvements (n=6) significantly decreased from these levels in IgG4-RD with limited organ’s involvement (n=7) and ANCA-associated vasculitis (n=10) (p<0.05).

Conclusion: When we diagnose IgG4-RD, it is important to differentiate hyper-IL-6 syndrome. FDG-PET/CT imaging and measuring serum ChE and T-cho levels might help us not only to evaluate widespread lesions and monitor disease activity in IgG4-RD, but also to differentiate other disorders. We must investigate further cases of IgG4-RD in order to elucidate its pathophysiology and mechanisms of development.


Disclosure:

K. Hamada,
None;

Y. Taniguchi,
None;

Y. Shimamura,
None;

K. Ogata,
None;

K. Inoue,
None;

T. Horino,
None;

Y. Kumon,
None;

K. Hirose,
None;

M. Hyodo,
None;

Y. Terada,
None.

  • Tweet
  • Email
  • Print

« Back to 2013 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/clinical-characteristics-in-japanese-patients-with-igg4-related-disease/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology